Oxaliplatin-based chemotherapy in patients aged at least 75 years with metastatic colorectal cancer: a post-hoc subgroup analysis if three phase II studies

MLA

Stefano Cordio, et al. “Oxaliplatin-Based Chemotherapy in Patients Aged at Least 75 Years with Metastatic Colorectal Cancer: A Post-Hoc Subgroup Analysis If Three Phase II Studies.” Annals of Oncology, vol. 30, July 2019, pp. iv19-iv20. EBSCOhost, https://doi.org/10.1093/annonc/mdz155.072.

APA

Stefano Cordio, G. Novello, Alfredo Butera, G. Rosati, G. Aprile, A. Avallone, G. Caputo, Domenico Bilancia, Giorgio Reggiardo, Giuseppina Blanco, A. Tucci, & Roberto Bordonaro. (2019). Oxaliplatin-based chemotherapy in patients aged at least 75 years with metastatic colorectal cancer: a post-hoc subgroup analysis if three phase II studies. Annals of Oncology, 30, iv19-iv20. https://doi.org/10.1093/annonc/mdz155.072

Chicago

Stefano Cordio, G. Novello, Alfredo Butera, G. Rosati, G. Aprile, A. Avallone, G. Caputo, et al. 2019. “Oxaliplatin-Based Chemotherapy in Patients Aged at Least 75 Years with Metastatic Colorectal Cancer: A Post-Hoc Subgroup Analysis If Three Phase II Studies.” Annals of Oncology 30 (July): iv19-iv20. doi:10.1093/annonc/mdz155.072.